In EDS ansehen

Characterization of Genetic Landscape and Novel Inflammatory Biomarkers in Patients With Adult‐Onset Still's Disease.

Gespeichert in:
Bibliographische Detailangaben
Titel: Characterization of Genetic Landscape and Novel Inflammatory Biomarkers in Patients With Adult‐Onset Still's Disease.
Autoren: Topping, Joanne, Chang, Leon, Nadat, Fatima, Poulter, James A., Ibbotson, Alice, Lara‐Reyna, Samuel, Watson, Christopher M., Carter, Clive, Pournara, Linda P., Zernicke, Jan, Ross, Rebecca L., Cargo, Catherine, Lyons, Paul A., Smith, Kenneth G. C., Del Galdo, Francesco, Rech, Jürgen, Fautrel, Bruno, Feist, Eugen, McDermott, Michael F., Savic, Sinisa
Quelle: Arthritis & Rheumatology; May2025, Vol. 77 Issue 5, p582-595, 14p
Schlagwörter: RHEUMATOID arthritis diagnosis, PROTEIN metabolism, GENETICS of rheumatoid arthritis, RESEARCH funding, RHEUMATOID arthritis, PROBABILITY theory, DESCRIPTIVE statistics, GENETIC variation, RNA, INTERFERONS, HEMATOPOIESIS, GENE expression profiling, INFLAMMATION, CYTOKINES, BIOMARKERS, SEQUENCE analysis, INTERLEUKINS
Abstract: Objective: Adult‐onset Still disease (AOSD) is a systemic autoinflammatory disorder (AID) of unknown etiology. Genetic studies have been limited. Here, we conducted detailed genetic and inflammatory biomarker analysis of a large cohort with AOSD to investigate the underlying pathology and identify novel targets for potential treatment. Methods: We investigated AOSD cases (n = 60) for rare germline and somatic variants using whole exome sequencing with virtual gene panels. Transcriptome profiles were investigated by bulk RNA sequencing whole blood. Cytokine profiling was performed on an extended patient cohort (n = 106) alongside measurements of NLRP3 inflammasome activation using a custom assay and type I interferon (IFN) score using a novel method. Results: We observed higher than expected frequencies of rare germline variants associated with monogenic AIDs in AOSD cases (AOSD 38.4% vs healthy controls [HCs] 20.4%) and earlier onset of putative somatic variants associated with clonal hematopoiesis of indeterminate potential. Transcriptome profiling revealed a positive correlation between Still Activity Score and gene expression associated with the innate immune system. ASC/NLRP3 specks levels and type I IFN scores were significantly elevated in AOSD cases compared with HCs (P = 0.0001 and 0.0015, respectively), in addition to several cytokines: interleukin (IL)‐6 (P < 0.0001), IL‐10 (P < 0.0075), IL‐12p70 (P = 0.0005), IL‐18 (P < 0.0001), IL‐23 (P < 0.0001), IFN‐α2 (P = 0.0009), and IFNγ (P = 0.0002). Conclusion: Our study shows considerable genetic complexity within AOSD and demonstrates the potential utility of the ASC/NLRP3 specks assay for disease stratification and targeted treatment. The enriched genetic variants identified may not by themselves be sufficient to cause disease, but may contribute to a polygenic model for AOSD. [ABSTRACT FROM AUTHOR]
Copyright of Arthritis & Rheumatology is the property of Wiley-Blackwell and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Datenbank: Complementary Index
Beschreibung
Abstract:Objective: Adult‐onset Still disease (AOSD) is a systemic autoinflammatory disorder (AID) of unknown etiology. Genetic studies have been limited. Here, we conducted detailed genetic and inflammatory biomarker analysis of a large cohort with AOSD to investigate the underlying pathology and identify novel targets for potential treatment. Methods: We investigated AOSD cases (n = 60) for rare germline and somatic variants using whole exome sequencing with virtual gene panels. Transcriptome profiles were investigated by bulk RNA sequencing whole blood. Cytokine profiling was performed on an extended patient cohort (n = 106) alongside measurements of NLRP3 inflammasome activation using a custom assay and type I interferon (IFN) score using a novel method. Results: We observed higher than expected frequencies of rare germline variants associated with monogenic AIDs in AOSD cases (AOSD 38.4% vs healthy controls [HCs] 20.4%) and earlier onset of putative somatic variants associated with clonal hematopoiesis of indeterminate potential. Transcriptome profiling revealed a positive correlation between Still Activity Score and gene expression associated with the innate immune system. ASC/NLRP3 specks levels and type I IFN scores were significantly elevated in AOSD cases compared with HCs (P = 0.0001 and 0.0015, respectively), in addition to several cytokines: interleukin (IL)‐6 (P < 0.0001), IL‐10 (P < 0.0075), IL‐12p70 (P = 0.0005), IL‐18 (P < 0.0001), IL‐23 (P < 0.0001), IFN‐α2 (P = 0.0009), and IFNγ (P = 0.0002). Conclusion: Our study shows considerable genetic complexity within AOSD and demonstrates the potential utility of the ASC/NLRP3 specks assay for disease stratification and targeted treatment. The enriched genetic variants identified may not by themselves be sufficient to cause disease, but may contribute to a polygenic model for AOSD. [ABSTRACT FROM AUTHOR]
ISSN:23265191
DOI:10.1002/art.43054